Centaurus Financial, Inc. Insulet Corp Transaction History

Centaurus Financial, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 17, 2023	BUY	$276.36 - $326.03 $92,304 - $108,894	334 New	334 $107,000
Q3 2022 Dec 05, 2022	SELL	$224.6 - $281.45 $224 - $281	-1 Reduced 0.17%	585 $134,000
Q2 2022 Aug 02, 2022	SELL	$186.4 - $279.02 $12,861 - $19,252	-69 Reduced 10.53%	586 $128,000
Q1 2022 May 13, 2022	SELL	$194.8 - $275.7 $77,920 - $110,280	-400 Reduced 37.91%	655 $174,000
Q3 2021 Nov 12, 2021	BUY	$260.36 - $307.27 $52,072 - $61,454	200 Added 23.39%	1,055 $300,000
Q1 2021 Apr 30, 2021	BUY	$235.95 - $293.05 $11,797 - $14,652	50 Added 6.21%	855 $223,000
Q4 2020 Jan 25, 2021	BUY	$215.97 - $265.89 $43,194 - $53,178	200 Added 33.06%	805 $206,000
Q3 2020 Nov 12, 2020	BUY	$192.55 - $236.59 $116,492 - $143,136	605 New	605 $143,000

730

63.2M

630K

854K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $19.8B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Centaurus Financial, Inc. with notifications on news.